This is a community-generated profile. If you would like to claim it, please .
- 4.8Highly ratedForesite Capital is highly rated on Glassdoor, with 4.8 out of 5 stars
- 4.8Strong LeadershipEmployees rate Foresite Capital 4.8/5 on Glassdoor for faith in leadership
- Website
- Location
- Company size
- 11-50 people
- Markets
Foresite Capital Funding
Nirav Bisarya + 1 more2 investors
Investors of Foresite Capital
Product & CS leader. 15 yrs exp. in B2B start-ups and SMB's. Software & Hardware, LP in 500 Startups & Foresite Capital, Root & Ubiquity Ventures.
Vu Nguyen
Pioneering AI and neuroscience to transform brain health
Investments of Foresite Capital
Jounce Therapeutics
WaveTec Vision
Karyopharm Therapeutics
SAGE Therapeutics
Adaptimmune
Aduro BioTech
Exit
REGENXBIO
Ardelyx
AveXis
Peloton Therapeutics
Allergen Research
Trivantis
Sequenta
Ivantis
Arcus Biosciences
Tarsa Therapeutics
Nexvet Biopharma
Intarcia Therapeutics
Protagonist Therapeutics
Wave Life Sciences
Audentes Therapeutics